Matthew Stevenson

Imperial Brands (United Kingdom)

Papers

1

Total Citations

85

H-Index

1

About

Dr. Matthew Stevenson is a leading toxicologist whose research focuses on the comparative safety assessment of tobacco and nicotine products, with a particular emphasis on developing advanced, human-relevant in vitro models. His most-cited work, "Toxicological comparison of cigarette smoke and e-cigarette aerosol using a 3D in vitro human respiratory model" (2019, 85 citations), represents a landmark contribution to the field. This study pioneered the use of a three-dimensional human respiratory tissue model to directly compare the toxicological effects of conventional cigarette smoke versus e-cigarette aerosol, addressing a critical public health need for robust, animal-free testing methods. By demonstrating that this 3D model could effectively differentiate the biological impacts of the two exposures, Dr. Stevenson provided a powerful new tool for regulatory science and product safety evaluation. His work is instrumental in advancing the "3Rs" principles—Replacement, Reduction, and Refinement of animal testing—while delivering actionable data on the relative risks of emerging nicotine delivery systems. Through this innovative approach, Dr. Stevenson has established himself as a key figure in modern inhalation toxicology.

Research Focus

Key Achievements

1
H-Index
1
Papers
85
Total Citations
85
Avg Citations/Paper
🏆 Most Cited Paper
Toxicological comparison of cigarette smoke and e-cigarette aerosol using a 3D in vitro human respiratory model
85 citations · 2019
📈 Most Prolific Year: 2019 (1 Papers)
🤝 Key Collaborators: 5
🏛 Institutions: Imperial Brands (United Kingdom)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago